Responses
Regular and young investigator award abstracts
Cellular therapies
104 BCMA-targeting CAR-T cells expanded in IL-15 have an improved phenotype for therapeutic use compared to those grown in IL-2 or IL-15/IL-7
Compose a Response to This Article
Other responses
No responses have been published for this article.
